Catheter for tissue dilation and drug delivery

• US 8,317,747 B2
• Filed: 04/16/2004
• Issued: 11/27/2012
• Est. Priority Date: 10/10/1996
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Kusleika, Richard S.
• Primary Examiner(s): VU, QUYNH-NHU HOANG
• Application Number:
  US10/825,309
• Publication Number:
  US 20040260239A1
• Time in Patent Office: 3,147 Days
• Field of Search: 604/96.01, 60410101-10103, 60410201-10203, 604/103.01, 604/103.02, 604/103.05, 604/103.06, 60410311-10313, 604/500, 604/523, 604/533, 604915-917, 604/919, 604/104, 606/194, 606/191, 606/192
• US Class Current: 604/101.02
• CPC Class Codes: A61M 2025/0057 Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
• CPC Class Codes: A61M 2025/1013 with concentrically mounted balloons, e.g. being independently inflatable
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 25/0032 characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
• CPC Class Codes: A61M 25/007 Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters
• CPC Class Codes: A61M 25/104 used for angioplasty

Abstract

A combination dilatation and drug delivery device includes a flexible catheter, a drug delivery sheath mounted to a distal end region of the catheter and a dilatation balloon also mounted to the catheter and contained within a compartment formed by the sheath. The sheath is radially expandable by supplying a liquid therapeutic agent to the compartment under a moderate pressure. The dilatation balloon is expandable by providing a dilatation fluid to the balloon under a much higher pressure. The sheath can be formed of a highly elastic material or can be made quite thin, and in either case is mounted independently of the dilatation balloon. Thus when radially expanded, the sheath is moved into a conforming contact with surrounding vascular tissue. The conforming contact protects tissue and the therapeutic agent from exposure to blood, and more effectively confines the therapeutic agent to the intended treatment area. The sheath either is naturally porous or is provided with multiple pores, whereby the therapeutic agent perfuses through the sheath into the surrounding tissue.

Claims

1. A process for treating tissue at a treatment site within a body lumen, comprising:

providing an elongate flexible catheter having a flexible treatment sheath mounted to a distal end region of the catheter and a dilatation balloon within the flexible treatment sheath, wherein the flexible treatment sheath is formed of an elastic material and the dilatation balloon is formed of a substantially inelastic material;

intraluminally advancing the elongate flexible catheter until the flexible treatment sheath is adjacent a predetermined treatment site;

while maintaining the dilatation balloon in an unexpanded condition, supplying a treatment fluid under pressure to a compartment formed by the treatment sheath, to elastically expand the treatment sheath radially into a substantially conforming contact with the surrounding tissue at the treatment site, cause the treatment fluid to pass through the treatment sheath from the compartment to the surrounding tissue, and maintain the treatment sheath expanded into said contact; and

while maintaining the treatment sheath in said substantially conforming contact with the surrounding tissue at the treatment site, radially expanding the dilatation balloon within the compartment, whereby the dilatation balloon acts radially upon the surrounding tissue through the treatment sheath to effect a dilatation of the surrounding tissue.

2. The process of claim 1 further comprising:

following said dilatation, radially contracting the dilatation balloon while maintaining the treatment sheath in said contact to administer the treatment fluid to the dilatated tissue; and

following said administering of the treatment fluid, discontinuing the supplying of the treatment fluid to allow the treatment sheath to radially contract under a residual elastic force.

3. The process of claim 2 further comprising:

after allowing the treatment sheath to radially contract, proximally withdrawing the catheter from the body lumen.

4. The process of claim 2 wherein:

said dilatation balloon radially enlargeable by supplying a dilatation fluid to a dilatation chamber formed by the balloon and the catheter, and wherein said contraction of the dilatation balloon comprises withdrawing the dilatation fluid from the dilatation chamber to substantially evacuate the dilatation balloon.

5. The process of claim 2 wherein:

said allowing the treatment sheath to radially contract comprises withdrawing the treatment fluid from the compartment.

6. The process of claim 1 wherein:

said advancing of the catheter includes intraluminally positioning a guidewire with a distal end thereof outside of the body, inserting the proximal end of the guidewire within the distal end of a guidewire lumen running through the catheter, and advancing the catheter distally relative to the guidewire.

7. The process of claim 1 wherein:

said supplying of the treatment fluid comprises providing the treatment fluid to the compartment via treatment fluid supply lumen of the catheter at a predetermined treatment fluid pressure.

8. The process of claim 7 wherein:

said supplying of the treatment fluid comprises causing the treatment fluid to perfuse through multiple pores in said treatment sheath.

9. The process of claim 1 further comprising:

while maintaining the treatment sheath in said substantially conforming contact, allowing a flow of body fluids through the catheter past the treatment site.

10. The process of claim 1, wherein said treatment sheath is formed of a biocompatible elastomeric material consisting essentially of at least one of the following:

latex, urethane, silicone, and a thermoplastic elastomer.

11. The process of claim 10, wherein the biocompatible elastomeric material has a modulus of elasticity in the range of 2,000 to 80,000 psi, said sheath has a uniform thickness in the range of 0.5-5 mils, whereby the treatment sheath elastically expands into said substantially conforming contact.